So far… Zimmer 3, Patients 0 in lawsuits over the NexGen Flex total knee

Zimmer Biomet logs 3rd win in NexGen Flex bellwether trials (MassDevice)
Zimmer Biomet (NYSE:ZBH) last week won its 3rd bellwether trial in the multi-district litigation brought over the NexGen Flex knee implant, after a federal jury in Illinois found against the plaintiff.
The FDA in 2007 cleared the NexGen Flex implant, designed to provide more flexibility than other knee replacement devices. Beverly Goldin is 1 of thousands of product liability plaintiffs in the MDL who allege that the device can’t withstand that extra flexion, despite the Warsaw, Ind.-based company’s marketing claims. The ...